Evaluation of frequency of nausea and vomiting as well as depression level in pregnant women

Şahin, Safiye Ağapinar; Özdemir, Kadir; Ünsal, Alaettin; Cevrioğlu, Arif Serhan; Beydağ, Kerime Derya

doi:10.12891/ceog3173.2016

Cited by 3 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Depressive symptoms and poor mental health are associated with severity of NVP. 164,165 Poor psychological health of women with HG is considered as the demoralisation of suffering from a prolonged, severe chronic illness and in this regard it is similar to mental health problems suffered in other chronic illnesses. 140…”

Section: [Evidence Level 2+]mentioning

confidence: 99%

“…[Evidence level 4] Clinical assessment should be considered for depression, anxiety and postnatal depression with appropriate referral. Depression and poor psychological health have been found to be associated with NVP and HG in numerous studies, 112,113,130,144,[154][155][156][157]161,[164][165][166][167][168][169] including a systematic review and meta-analysis, but resulted from the disease and were not the cause of HG or NVP. 126 A UK wide survey of 5071 participants found a quarter of those suffering HG occasionally reported suicidal ideation and 6.6% regularly considered suicide due to the severity of the condition, 4.9% had a termination of pregnancy (TOP) due to HG and 52.1% considered TOP due to HG.…”

Section: [Evidence Level 2+]mentioning

confidence: 99%

See 1 more Smart Citation

The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green‐top Guideline No. 69)

Nelson‐Piercy,

Dean,

Shehmar

et al. 2024

BJOG

View full text Add to dashboard Cite

Key recommendations An objective and validated index of nausea and vomiting such as the Pregnancy‐Unique Quantification of Emesis (PUQE) and HyperEmesis Level Prediction (HELP) tools can be used to classify the severity of NVP and HG. [Grade C] Ketonuria is not an indicator of dehydration and should not be used to assess severity. [Grade A] There are safety and efficacy data for first line antiemetics such as anti (H1) histamines, phenothiazines and doxylamine/pyridoxine (Xonvea®) and they should be prescribed initially when required for NVP and HG (Appendix III). [Grade A] There is evidence that ondansetron is safe and effective. Its use as a second line antiemetic should not be discouraged if first line antiemetics are ineffective. Women can be reassured regarding a very small increase in the absolute risk of orofacial clefting with ondansetron use in the first trimester, which should be balanced with the risks of poorly managed HG. [Grade B] Metoclopramide is safe and effective and can be used alone or in combination with other antiemetics. [Grade B] Because of the risk of extrapyramidal effects metoclopramide should be used as second‐line therapy. Intravenous doses should be administered by slow bolus injection over at least 3 minutes to help minimise these. [Grade C] Women should be asked about previous adverse reactions to antiemetic therapies. If adverse reactions occur, there should be prompt cessation of the medications. [GPP] Normal saline (0.9% NaCl) with additional potassium chloride in each bag, with administration guided by daily monitoring of electrolytes, is the most appropriate intravenous hydration. [Grade C] Combinations of different drugs should be used in women who do not respond to a single antiemetic. Suggested antiemetics for UK use are given in Appendix III. [GPP] Thiamine supplementation (either oral 100 mg tds or intravenous as part of vitamin B complex (Pabrinex®)) should be given to all women admitted with vomiting, or severely reduced dietary intake, especially before administration of dextrose or parenteral nutrition. [Grade D] All therapeutic measures should have been tried before considering termination of pregnancy. [Grade C]

show abstract

Section: [Evidence Level 2+]mentioning

confidence: 99%

Section: [Evidence Level 2+]mentioning

confidence: 99%

The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green‐top Guideline No. 69)

Nelson‐Piercy,

Dean,

Shehmar

et al. 2024

BJOG

View full text Add to dashboard Cite

show abstract

The association between quality of life and complementary and alternative medicine use in pregnant women with hyperemesis gravidarum

Iskender

Kaplan

2021

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim This study investigated the association between quality of life and complementary and alternative medicine (CAM) use in pregnant women with hyperemesis gravidarum in Turkey. Methods This cross‐sectional descriptive study was conducted between October 2017 and July 2018 in Turkey. The sample consisted of 240 pregnant women with hyperemesis gravidarum. Data were collected using a Demographic Information Form, the Index of Nausea, Vomiting, Retching, and the 36‐item Short‐Form Health Survey. Results The majority (84.2%) of participants stated that they used CAM, mostly “biologically based therapies” (97.5%). They were most satisfied with the “mental and physical treatments” (3.71 ± 1.74). Participants who did not use CAM had a higher quality of life “emotional role” than those who used CAM (p = 0.038). However, there were no statistically significant differences in the other quality of life subscale scores between the two groups. Conclusion There is limited evidence for the association between quality of life and CAM use in pregnant women with hyperemesis gravidarum in Turkey. Therefore, more evidence‐based research is warranted to evaluate the association between CAM use and quality of life in pregnant women with hyperemesis gravidarum.

show abstract

Hi̇peremezi̇s Gravi̇darumlu Gebelerde Depresi̇f Semptomlar Ve Ki̇şi̇li̇k Özelli̇kleri̇ni̇n Bulanti Kusma Şi̇ddeti̇ İle İli̇şki̇si̇

NACAR,

DERMAN,

GÜZEL İNAL

2023

Samsun Sağlık Bilimleri Dergisi

View full text Add to dashboard Cite

Amaç: Araştırmanın amacı, hiperemezis gravidarumlu gebelerde depresif semptomlar ve kişilik özelliklerinin bulantı kusma şiddeti ile ilişkisinin belirlenmesidir. Yöntem: Tanımlayıcı ve ilişki arayıcı tipte olan araştırma 100 hiperemezis gravidarumlu gebe ile yürütülmüştür. Araştırma İç Anadolu Bölgesinde bulunan bir ildeki bir kamu hastanesinin gebe polikliniğinde yapılmıştır. Araştırma verileri, Katılımcı Tanıtım Formu, Gebeliğe Özgü Bulantı Kusma Değerlendirme Skalası, Cervantes Kişilik Ölçeği ve Edinburgh Postpartum Depresyon Ölçeği kullanılarak elde edilmiştir. Araştırma verilerinin değerlendirilmesinde tanımlayıcı istatistikler, ki kare testi, ANOVA testi kullanılmıştır. Bulgular: Araştırmada gebelerin %60’ ının bulantı kusma şiddetinin orta düzeyde olduğu saptanmıştır. Bulantı kusmanın gebelerin %87’ sinin günlük aktivitesini etkilediği, %90’ nın fiziksel aktivitesini etkilediği görülmüştür. Bulantı kusması şiddetli olan gebelerin daha fazla depresif semptom gösterdiği saptanmıştır (p=0.036). Kişilik özellikleri ile bulantı kusma şiddeti arasında ise anlamlı bir ilişki bulunmamıştır (p>0.05). Sonuç ve öneriler: Araştırmada şiddetli bulantı kusması olan gebelerin daha fazla depresif semptom gösterdiği bulunmuştur. Hiperemezis gravidarumlu gebeler ile çalışan sağlık profesyonellerinin hastalarını depresif semptomlar yönünden değerlendirmesi önerilmektedir.

show abstract

Evaluation of frequency of nausea and vomiting as well as depression level in pregnant women

Abstract: Objective: To determine the frequency of nausea and vomiting in pregnant (NVP) women, review associated factors, and evaluate the depression level. Materials and Methods: The study is a cross-sectional research conducted in pregnant women who applied to

Cited by 3 publications

References 20 publications

The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green‐top Guideline No. 69)

The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green‐top Guideline No. 69)

The association between quality of life and complementary and alternative medicine use in pregnant women with hyperemesis gravidarum

Hi̇peremezi̇s Gravi̇darumlu Gebelerde Depresi̇f Semptomlar Ve Ki̇şi̇li̇k Özelli̇kleri̇ni̇n Bulanti Kusma Şi̇ddeti̇ İle İli̇şki̇si̇

Contact Info

Product

Resources

About